APA (7th ed.) Citation

Kamen, D. L., Wallace, C., Li, Z., Wyatt, M., Paulos, C., Wei, C., . . . Gilkeson, G. (2022). Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus science & medicine, 9(1), e000704. https://doi.org/10.1136/lupus-2022-000704

Chicago Style (17th ed.) Citation

Kamen, Diane L., et al. "Safety, Immunological Effects and Clinical Response in a Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells in Patients with Treatment Refractory SLE." Lupus Science & Medicine 9, no. 1 (2022): e000704. https://doi.org/10.1136/lupus-2022-000704.

MLA (9th ed.) Citation

Kamen, Diane L., et al. "Safety, Immunological Effects and Clinical Response in a Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells in Patients with Treatment Refractory SLE." Lupus Science & Medicine, vol. 9, no. 1, 2022, p. e000704, https://doi.org/10.1136/lupus-2022-000704.